Finally, we tested the regulatory function of these engineered B cells in vivo for their capacity to protect NOD.Scid mice from diabetes development by adoptively transferring pathogenic antigen-specific CD8+ or CD4+ T cells into NOD.Scid hosts. This evidence concerns the gene CD8A and diabetes mellitus.